<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Recash test site | Thisted Dissing | Activity</title>
	<link>https://recash.wpsoul.net/members/grainwound2/activity/</link>
	<atom:link href="https://recash.wpsoul.net/members/grainwound2/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Thisted Dissing.</description>
	<lastBuildDate>Thu, 21 May 2026 03:48:37 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">f51b9848ad8a06aa4c875f98612980dc</guid>
				<title>Thisted Dissing posted an update: Rivaroxaban (RXB), an oral direct factor Xa inhibitor, [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/50777/</link>
				<pubDate>Wed, 11 Dec 2024 14:00:43 +0000</pubDate>

									<content:encoded><![CDATA[<p>Rivaroxaban (RXB), an oral direct factor Xa inhibitor, presents innovative therapeutic profile. However, RXB has shown adverse effects, mainly due to pharmacokinetic limitations, highlighting the importance of developing more effective formulations. Therefore, this work aims at the preparation, physicochemical characterization and in vitro&hellip;<span class="activity-read-more" id="activity-read-more-50777"><a href="https://recash.wpsoul.net/activity/p/50777/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d6dd2558e30d2cc60b610cf558b05e14</guid>
				<title>Thisted Dissing became a registered member</title>
				<link>https://recash.wpsoul.net/activity/p/50680/</link>
				<pubDate>Wed, 11 Dec 2024 13:39:56 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>